Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2005 13
2006 2
2007 4
2008 13
2009 45
2010 69
2011 74
2012 72
2013 113
2014 472
2015 145
2016 160
2017 182
2018 170
2019 211
2020 207
2021 193
2022 171
2023 147
2024 159
2025 123

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,748 results

Results by year

Filters applied: . Clear all
Page 1
Persistent sex disparities in access to dolutegravir-based antiretroviral therapy in Latin America and the Caribbean: results from a retrospective observational study using data from 2017 to 2022.
Fonseca FF, Ranadive P, Shepherd BE, Ferreira FGF, Rodríguez MF, Machado DM, Rouzier V, Varela D, Maruri F, Ribeiro P, Grinsztejn B, Wagner Cardoso S, Veloso VG, Castilho JL, Jalil EM; CCASAnet. Fonseca FF, et al. J Int AIDS Soc. 2025 Jul;28(7):e26470. doi: 10.1002/jia2.26470. J Int AIDS Soc. 2025. PMID: 40635404 Free PMC article.
Non-communicable disease (NCD) risk among people living with HIV in KwaZulu-Natal, South Africa: evidence from a randomised trial of community-based differentiated service delivery.
Sahu M, Szpiro AA, van Rooyen H, Asiimwe S, Shahmanesh M, Roberts DA, Krows ML, Sausi K, Sithole N, Schaafsma T, Baeten JM, Shapiro AE, van Heerden A, Barnabas RV. Sahu M, et al. J Int AIDS Soc. 2025 Jul;28 Suppl 3(Suppl 3):e26513. doi: 10.1002/jia2.26513. J Int AIDS Soc. 2025. PMID: 40623916 Free PMC article. Clinical Trial.
Early findings from the integration of hypertension care into differentiated service delivery models for HIV in Uganda: a mixed-method study.
Kiggundu JB, Semitala FC, Lipoto CF, Giibwa L, Twine R, Mwaka S, Ayebare F, Kiwala C, Magambo EN, Mutungi G, Ssinabulya I, Spiegelman D, Kayima J, Muddu M, Schwartz JI, Katahoire AR, Longenecker CT. Kiggundu JB, et al. J Int AIDS Soc. 2025 Jul;28 Suppl 3(Suppl 3):e26499. doi: 10.1002/jia2.26499. J Int AIDS Soc. 2025. PMID: 40622382 Free PMC article. Clinical Trial.
Scale of differentiated service delivery implementation in HIV care facilities in low- and middle-income countries: a global facility survey.
Fernández Villalobos NV, Helfenstein F, Khol V, Twizere C, Secco M, Castelnuovo B, Huwa J, Tiendredbeogo T, Wester CW, Fong SM, Murenzi G, Caro-Vega Y, Lyamuya RE, Rafael I, Zannou DM, Petoumenos K, Nsonde DM, Pinto J, Wools-Kaloustian K, Moore CB, Takassi OE, Kiertiburanakul S, Awoh RA, Ali SM, Fatti G, Malateste K, Zaniewski E, Ballif M; International epidemiology Databases to Evaluate AIDS. Fernández Villalobos NV, et al. J Int AIDS Soc. 2025 Jul;28 Suppl 3(Suppl 3):e26477. doi: 10.1002/jia2.26477. J Int AIDS Soc. 2025. PMID: 40622380 Free PMC article.
Introducing differentiated service delivery models for tuberculosis treatment: a pilot project to inform national policy in Uganda.
Ferroussier-Davis O, Lukoye D, Alwedo S, Mudiope MN, Nalunjogi J, Kirenga JB, Kabanda JN, Kalamya JN, Nasasira B, Birabwa E, Dejene S, Murungi M, Ddumba I, Moore B, Burua A, Luzze H, Quinto E, Sekadde M, Byaruhanga R, Ajuna P, Arinaitwe I, Katureebe C, Namuwenge P, Adler MR, Turyahabwe S. Ferroussier-Davis O, et al. J Int AIDS Soc. 2025 Jul;28 Suppl 3(Suppl 3):e26483. doi: 10.1002/jia2.26483. J Int AIDS Soc. 2025. PMID: 40622376 Free PMC article.
A prospective cohort study of the SEARCH integrated HIV/hypertension community health worker-led intervention in rural Kenya and Uganda.
Hickey MD, Owaraganise A, Ogachi S, Sunday H, Aoko C, Sang N, Agengo G, Kabami J, Kakande E, Mugoma EW, Schwab J, Sutter N, Black D, Muiru A, Chamie G, Petersen ML, Balzer LB, Bukusi EA, Havlir DV, Kamya MR, Ayieko J. Hickey MD, et al. J Int AIDS Soc. 2025 Jul;28 Suppl 3(Suppl 3):e26500. doi: 10.1002/jia2.26500. J Int AIDS Soc. 2025. PMID: 40622370 Free PMC article. Clinical Trial.
Improving PrEP access for adolescent girls and young women: a descriptive analysis of community-based PrEP delivery in the DREAMS programme in Zambia.
Musheke M, Pry JM, Sikazwe I, Muyunda WJ, Chiyenu K, Siame CM, Khondowe WK, Mushiki B, Mwaba MM, Zulu P, Mwape F, Siamasuku B, Shula D, Mweemba MB, Kanene C, Phiri A, Herce ME. Musheke M, et al. J Int AIDS Soc. 2025 Jul;28 Suppl 3(Suppl 3):e26484. doi: 10.1002/jia2.26484. J Int AIDS Soc. 2025. PMID: 40622362 Free PMC article.
High acceptability, feasibility and sustainability of a direct-to-pharmacy differentiated PrEP delivery model in public health HIV clinics in Kenya: perspectives of PrEP clients and healthcare providers.
Owidi E, Ngure K, Ogello V, Wairimu N, Etyang' L, Waituika W, Mwangi M, Mwangi D, Maina S, Irungu E, Kiptinness C, Mugo N, Mugwanya K; Efficiency Study Team. Owidi E, et al. J Int AIDS Soc. 2025 Jul;28 Suppl 3(Suppl 3):e26442. doi: 10.1002/jia2.26442. J Int AIDS Soc. 2025. PMID: 40622359 Free PMC article.
Estimated impact of long-acting injectable PrEP in South Africa: a model comparison analysis.
Stansfield SE, Moore M, Jamieson L, Meyer-Rath G, Johnson LF, Kaftan D, Bershteyn A, Smith J, Cambiano V, Bansi-Matharu L, Phillips A, Heitner J, Barnabas RV, Hanscom B, Donnell DJ, Boily MC, Dimitrov D. Stansfield SE, et al. J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26453. doi: 10.1002/jia2.26453. J Int AIDS Soc. 2025. PMID: 40600502 Free PMC article.
PrEP choice in the real world: Results of a prospective cohort study describing uptake and use patterns of oral PrEP and the dapivirine vaginal ring among women in sub-Saharan Africa.
Fonner VA, Irungu E, Conlon M, Akello CA, Gwavava E, K'Orimba K, Naidoo NP, Jeckonia P, Mahaka I, Mullick S, Chabela M, Drysdale R, Kabongo J, Kiruki M, Segawa I, Dobbie M, Marake N, Mudiope P, Subedar H, Wafula R, Kazibwe A, Reed J, Kripke K, Taylor D, Lee MT, Chidumwa G, Chivafa A, Soothoane R, Eichleay M, Mayo A, McGuire C, McClure T, Yemeke T, Torjesen K; CATALYST study team. Fonner VA, et al. J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26457. doi: 10.1002/jia2.26457. J Int AIDS Soc. 2025. PMID: 40600484 Free PMC article.
Strategies for implementing long-acting cabotegravir for PrEP in US clinics serving Black women: interim healthcare provider findings from the EBONI study.
Nelson KL, Evans Cooper T, Lawson Y, Baker D, Mocherla S, Dieterich M, Hodge T, Dyson A, Sutherland-Philips D, Swygard H, Petty L, Jeffery P, Sutton K, Bonner CP, Andrews SM, Chang S, Budnik P, Smith K, de Ruiter A, Czarnogorski M, Pilgrim N. Nelson KL, et al. J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26497. doi: 10.1002/jia2.26497. J Int AIDS Soc. 2025. PMID: 40600480 Free PMC article.
Finally, PrEP choices! But will clients ever have a choice?
Green KE, Ngure K, Eakle R, Phanuphak N, Reed J. Green KE, et al. J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26505. doi: 10.1002/jia2.26505. J Int AIDS Soc. 2025. PMID: 40600475 Free PMC article. No abstract available.
Feasibility and acceptability of persons on long-acting cabotegravir for HIV prevention in the SEARCH Dynamic Choice HIV Prevention trial extension in rural Kenya and Uganda: a longitudinal cohort study.
Kakande ER, Balzer LB, Kabami J, Ayieko J, Chamie G, Sutter N, Sunday H, Nyabuti M, Litunya J, Camlin C, Johnson-Peretz J, Temple J, Lavoy G, Koss C, Czarnogorski M, Petersen ML, Kamya MR, Havlir DV. Kakande ER, et al. J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26465. doi: 10.1002/jia2.26465. J Int AIDS Soc. 2025. PMID: 40600471 Free PMC article.
Exploring perceptions and preferences for PrEP choice and of an mHealth intervention: insights from the ImPrEP CAB-Brasil study.
Pimenta C, Mann CG, Hoagland B, Carvalheira E, Jalil C, Benedetti M, Fernandes N, Coutinho C, Jalil EM, Secco Torres Silva M, Trefiglio R, Farias A, Mourão MPG, Madruga JV, de Lima JN, Zonta R, O'Malley G, Veloso VG, Grinsztejn B, Torres TS; ImPrEP CAB‐Brasil Study. Pimenta C, et al. J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26493. doi: 10.1002/jia2.26493. J Int AIDS Soc. 2025. PMID: 40600468 Free PMC article.
The science at HIVR4P 2024: The era of choice in biomedical HIV prevention.
Grinsztejn B, Appay V, Bekker LG, Beyrer C, Donnell D, Sanchez J, Canagasabey D, Coutinho C, Ganor Y, Muturi-Kioi V, Ortblad KF, Cooney E, Devisich G, Ellenberg P, Ghiglione Y, K'Orimba K, Ssemambo PK, Ludwig-Barron NT, Mielke DK, Mullick R, Muthui MK, Radusky PD, Sendaula E, Tirmizi SRH, Sanchez AVM, Vega J, Pebody R. Grinsztejn B, et al. J Int AIDS Soc. 2025 Jul;28(7):e70001. doi: 10.1002/jia2.70001. J Int AIDS Soc. 2025. PMID: 40598755 Free PMC article.
Low sensitivity of the fourth-generation antigen/antibody HIV rapid diagnostic test Determine™ HIV Early Detect for detection of acute HIV infection at the point of care in rural Eswatini: a diagnostic accuracy study.
Ciglenecki I, Ntshalintshali N, Mukooza E, Lekelem S, Mavimbela M, Dlamini S, Dube L, Mabuza N, Haile M, Ellman T, Flores A, Keiser O, Matse S, de la Tour R, Calmy A, Kerschberger B. Ciglenecki I, et al. J Int AIDS Soc. 2025 Jul;28(7):e26517. doi: 10.1002/jia2.26517. J Int AIDS Soc. 2025. PMID: 40579874 Free PMC article.
Poor post-exposure prophylaxis completion despite improvements in post-violence service delivery in 14 PEPFAR-supported sub-Saharan African countries, 2018-2023.
Kanagasabai U, Davis SM, Thorsen V, Rowlinson E, Laterra A, Hegle J, Angumua C, Ekra A, Mpingulu M, Getahun M, Sida F, Mndzebele P, Kambona C, Ramphalla P, Mtingwi E, Msungama W, Duffy M, Adewumi B, Olotu E, Sebeza J, Kitalile J, Apondi R, Muleya C, Cain M. Kanagasabai U, et al. J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26469. doi: 10.1002/jia2.26469. J Int AIDS Soc. 2025. PMID: 40569898 Free PMC article.
Limited awareness and use of HIV post-exposure prophylaxis among people vulnerable to HIV acquisition in Western Kenya: a cross-sectional analysis.
Schluck G, Romo ML, Kosgei J, Thigpen MC, Burns N, Bor R, Langat D, Akoth C, Yates A, Charles C, Qian H, Gayle B, Yacovone M, Sawe F, Crowell TA; Multinational Observational Cohort of HIV and other Infections (MOCHI) Study Group. Schluck G, et al. J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26472. doi: 10.1002/jia2.26472. J Int AIDS Soc. 2025. PMID: 40569897 Free PMC article.
Untapped potential of post-exposure prophylaxis in sub-Saharan Africa: a comparative analysis of PEP implementation planning in Kenya, Mozambique, Nigeria, Uganda and Zambia.
Resar D, Mwamelo AJ, Olowu A, Drakes J, Macul H, Gusmao E, Franks J, Otubu N, Osowale O, Abudiore O, Mwamba T, Silondwa M, Haimbe P, Shakwelele H, Otobo E, Borain R, Honu M, Igbomezie CC, Obermeyer C, Vernon T, Hatzold K, Ingold H, Rodolph M, Jenkins SY. Resar D, et al. J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26471. doi: 10.1002/jia2.26471. J Int AIDS Soc. 2025. PMID: 40569874 Free PMC article.
Online delivery of oral HIV pre- and post-exposure prophylaxis: findings from the ePrEP Kenya pilot.
Kiptinness C, Naik P, Kareithi T, Thuo N, Okello P, Culquichicon C, Rafferty M, Abdulrashid S, Jomo E, Nyamasyo N, Wood T, Mendonca R, Malen RC, Dettinger JC, Pintye J, Mwangi J, Stergachis A, Onentia J, Curran K, Mugambi ML, Were D, Ngure K, Sharma M, Ortblad KF; ePrEP Kenya team. Kiptinness C, et al. J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26468. doi: 10.1002/jia2.26468. J Int AIDS Soc. 2025. PMID: 40569864 Free PMC article. Clinical Trial.
Strengthening post-exposure prophylaxis uptake among survivors of sexual violence through immediate access at police stations in Nigeria's Federal Capital Territory.
Adewumi B, Cain M, Kanagasabai U, Dahal S, Collins-Kalu D, Ayuba AM, Adamu V, Efuntoye T, Ayeni C, Omuh H, Nwafor C, Ajuwon AR, Oluwaniyi O, Dakum P, Oki-Emesim R, Daggash F, Fagbamigbe O. Adewumi B, et al. J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26460. doi: 10.1002/jia2.26460. J Int AIDS Soc. 2025. PMID: 40569860 Free PMC article.
The unintended outcome: a retrospective cross-sectional study using a urine lateral flow assay to detect ART use reveals non-disclosure of taking ART in South Africa's public health system.
Sithole N, Govender I, Spinelli M, Smit T, Cibane S, Zwane M, Phakathi N, Krows M, Nkosi B, Seeley J, Barnabas RV, Siedner MJ, Moshabela M, Celum C, Grant A, Gandhi M, Shapiro AE. Sithole N, et al. J Int AIDS Soc. 2025 Jun;28(6):e26515. doi: 10.1002/jia2.26515. J Int AIDS Soc. 2025. PMID: 40551583 Free PMC article.
Factors associated with awareness of and willingness to use PrEP among stable, heterosexual HIV-serodifferent couples in seven African countries, 2019-2022.
Sharpe JD, Laws RL, West CA, Djomand G, Omolo J, Ramaabya D, Li M, Dlamini S, Motebang M, Marake N, Singano V, Ozituosauka W, McCabe C, Sathane I, Kancheya N, Chisenga T, Malaba R, Ncube G, Philip NM, Biraro S, Charurat ME, Rolle I, Voetsch AC. Sharpe JD, et al. J Int AIDS Soc. 2025 Jun;28(6):e26446. doi: 10.1002/jia2.26446. J Int AIDS Soc. 2025. PMID: 40534141 Free PMC article.
HIV drug resistance, early treatment outcomes and impact of guidelines compliance after protease inhibitor-based second-line failure in a dedicated resistance clinic in western Kenya: a retrospective cohort study.
Humphrey JM, Ali SM, DeLong A, Novitsky V, Sang E, Jawed B, Kemboi E, Ngetich C, Goodrich S, Gardner A, Hogan JW, Kantor R. Humphrey JM, et al. J Int AIDS Soc. 2025 Jun;28(6):e26523. doi: 10.1002/jia2.26523. J Int AIDS Soc. 2025. PMID: 40490983 Free PMC article.
Household economic impact of HIV-associated cryptococcal meningitis in five countries in Southern and Eastern Africa.
Lawrence DS, Muthoga C, Adams J, Ndweni AB, Boulware DR, Chawinga C, Comins K, Dziwani EN, Hlupeni A, Hosseinipour MC, Jjunju S, Kanyama C, Leeme TB, Meintjes G, Meya DB, Mosepele M, Moyo M, Mwandumba HC, Muzoora C, Ndhlovu CE, Nuwagira E, Schutz C, Tugume L, Williams D, Molloy SF, Boyer-Chammard T, Youssouf N, Jaffar S, Niessen LW, Harrison TS, Cunnama L, Jarvis JN; AMBITION Study Group. Lawrence DS, et al. J Int AIDS Soc. 2025 Jun;28(6):e26441. doi: 10.1002/jia2.26441. J Int AIDS Soc. 2025. PMID: 40474529 Free PMC article.
Analytical treatment interruption among women with HIV in southern Africa who received VRC01 or placebo in the Antibody Mediated Prevention Study: ATI stakeholder engagement, implementation and early clinical data.
Karuna S, Laher F, Dadabhai S, Yu PC, Grove D, Orrell C, Makhema J, Hosseinipour MC, Mathew CA, Brumskine W, Mgodi N, Andrew P, Gama L, Karg C, Broder G, Baepanye K, Lucas J, Andrasik M, Takuva S, Villaran M, Takalani A, Tressler R, Soto-Torres L, Woodward Davis AS, Dhai A, Sanne IM, Cohen MS, Corey L, Gray G, deCamp AC, Bar KJ. Karuna S, et al. J Int AIDS Soc. 2025 Jun;28(6):e26495. doi: 10.1002/jia2.26495. J Int AIDS Soc. 2025. PMID: 40462491 Free PMC article. Clinical Trial.
The lavender purge.
Mayer KH. Mayer KH. J Int AIDS Soc. 2025 May;28(5):e26509. doi: 10.1002/jia2.26509. J Int AIDS Soc. 2025. PMID: 40413612 Free PMC article. No abstract available.
No significant drug-drug interaction between oral TAF-based PrEP and feminizing hormone therapy among transgender women in Thailand: the iFACT-3 study.
Hiransuthikul A, Thammajaruk N, Kerr S, Janamnuaysook R, Nonenoy S, Hongchookiat P, Trichavaroj R, Tawon Y, Boonruang J, Teeratakulpisarn N, Cressey TR, Anderson PL, Phanuphak N; iFACT3 study team. Hiransuthikul A, et al. J Int AIDS Soc. 2025 May;28(5):e26502. doi: 10.1002/jia2.26502. J Int AIDS Soc. 2025. PMID: 40390323 Free PMC article.
Status of HIV vaccine development: progress and promise.
Haynes BF, Saunders KO, Hahn BH, Wiehe K, Baden LR, Shaw GM. Haynes BF, et al. J Int AIDS Soc. 2025 May;28(5):e26489. doi: 10.1002/jia2.26489. J Int AIDS Soc. 2025. PMID: 40375607 Free PMC article. No abstract available.
"It gives me the strength and courage to take care of myself": a qualitative exploration of experiences with STI testing among women who initiated PrEP during pregnancy in Western Kenya.
Mogaka JN, Concepcion T, Abuna F, Akim E, Morroni C, Mussa A, Mugambi M, Aketch H, Obatsa S, Webel AR, Kinuthia J, Ngure K, Beima-Sofie KM, John-Stewart G, Pintye J. Mogaka JN, et al. J Int AIDS Soc. 2025 Apr;28(4):e26464. doi: 10.1002/jia2.26464. J Int AIDS Soc. 2025. PMID: 40268677 Free PMC article. Clinical Trial.
Machine learning to improve HIV screening using routine data in Kenya.
Friedman JD, Mwangi JM, Muthoka KJ, Otieno BA, Odhiambo JO, Miruka FO, Nyagah LM, Mwele PM, Obat EO, Omoro GO, Ndisha MM, Kimanga DO. Friedman JD, et al. J Int AIDS Soc. 2025 Apr;28(4):e26436. doi: 10.1002/jia2.26436. J Int AIDS Soc. 2025. PMID: 40254897 Free PMC article.
Differences in clinical characteristics between adolescents and young adults with perinatally and sexually acquired HIV in the Asia-Pacific region.
Phatharodom P, Maleesatharn A, Sudjaritruk T, Khusuwan S, Petoumenos K, Aurpibul L, Chaiwarith R, Giles ML, Quy DT, Nimkar S, Widhani A, Tanuma J, Law M, Sohn AH, Chokephaibulkit K; IeDEA Asia‐Pacific. Phatharodom P, et al. J Int AIDS Soc. 2025 Apr;28(4):e26400. doi: 10.1002/jia2.26400. J Int AIDS Soc. 2025. PMID: 40200597 Free PMC article.
Exploring potential drug-drug interactions between masculinizing hormone therapy and oral pre-exposure prophylaxis (F/TDF and F/TAF) among transgender men (iMACT study): a randomized, open-label pharmacokinetic study in Thailand.
Hiransuthikul A, Thammajaruk N, Kerr S, Janamnuaysook R, Nonenoy S, Hongchookiat P, Trichavaroj R, Tawon Y, Boonruang J, Teeratakulpisarn N, Cressey TR, Anderson PL, Phanuphak N; iMACT study team. Hiransuthikul A, et al. J Int AIDS Soc. 2025 Apr;28(4):e26445. doi: 10.1002/jia2.26445. J Int AIDS Soc. 2025. PMID: 40195242 Free PMC article. Clinical Trial.
Characterizing adolescent and youth-friendly HIV services: a cross-sectional assessment across 16 global sites.
Embleton L, Sudjaritruk T, Machado DM, Chihota B, Musabyimana F, Jesson J, Apondi E, Puthanakit T, Luque MT, van Dongen NE, Murenzi G, Amorissani-Folquet M, Kwena Z, Perreras N, Rouzier V, Lyamuya R, Anderson K, Elul B, Leroy V, Enane LA, Martin R, Lancaster K, Parcesepe AM, Vreeman R; IeDEA. Embleton L, et al. J Int AIDS Soc. 2025 Apr;28(4):e26437. doi: 10.1002/jia2.26437. J Int AIDS Soc. 2025. PMID: 40181514 Free PMC article.
Evidence from high-income countries on the effectiveness of psychosocial interventions to improve mental health, wellbeing and quality of life for adults living with HIV: a systematic review and meta-analysis.
Miltz AR, Sewell J, Nakagawa F, Rein SM, Sherr L, Rodger A, Phillips AN, vanLuenen S, Garnefski N, Kraaij V, Smith CJ, Cambiano V, Lampe FC. Miltz AR, et al. J Int AIDS Soc. 2025 Apr;28(4):e26424. doi: 10.1002/jia2.26424. J Int AIDS Soc. 2025. PMID: 40141017 Free PMC article. Review.
Comorbidities and HIV-related factors associated with mental health symptoms and unhealthy substance use among older adults living with HIV in low- and middle-income countries: a cross-sectional study.
Ross JL, Rupasinghe D, Chanyachukul T, Crabtree Ramírez B, Murenzi G, Kwobah E, Mureithi F, Minga A, Marbaniang I, Perazzo H, Parcesepe A, Goodrich S, Chimbetete C, Mensah E, Maruri F, Thi Hoai Nguyen D, López-Iñiguez A, Lancaster K, Byakwaga H, Tlali M, Plaisy MK, Nimkar S, Moreira R, Anastos K, Semeere A, Wandeler G, Jaquet A, Sohn A; Sentinel Research Network of the International epidemiology Databases to Evaluate AIDS. Ross JL, et al. J Int AIDS Soc. 2025 Mar;28(3):e26434. doi: 10.1002/jia2.26434. J Int AIDS Soc. 2025. PMID: 40045453 Free PMC article.
Early impacts of the PEPFAR stop-work order: a rapid assessment.
Lankiewicz E, Sharp A, Drake P, Sherwood J, Macharia B, Ighodaro M, Honermann B, Russell A. Lankiewicz E, et al. J Int AIDS Soc. 2025 Feb;28(2):e26423. doi: 10.1002/jia2.26423. J Int AIDS Soc. 2025. PMID: 39964153 Free PMC article. No abstract available.
Preferences for HIV pre-exposure prophylaxis formulations and delivery among young African women: results of a discrete choice experiment.
Dlamini WW, Mirembe BG, Krows ML, Peacock S, Kotze PL, Selepe P, Smit J, Mandona N, Louw C, Nuwagaba-Biribonwoha H, Omollo VO, Zwane Z, Panchia R, Mwelase N, Senne M, Naidoo L, Chihana R, Delany-Moretlwe S, Gill K, MacDonald P, van Heerden A, Bosman S, Peters RPH, du Preez P, Ward A, Celum C, Heffron R, Velloza J; INSIGHT Study Team. Dlamini WW, et al. J Int AIDS Soc. 2025 Feb;28(2):e26422. doi: 10.1002/jia2.26422. J Int AIDS Soc. 2025. PMID: 39956930 Free PMC article.
Early initiation of fast-track care for persons living with HIV initiating dolutegravir-based regimens during a period of severe civil unrest in Port-au-Prince, Haiti: a pilot randomized trial.
Marc JB, Pierre S, Ducatel O, Homeus F, Zion A, Rivera VR, Dorvil N, Severe P, Guiteau C, Rouzier V, Katz IT, Duchatelier CF, Forestal GPL, Jean J, Bernadin G, Dumont ED, Riche RCB, Pape JW, Koenig SP. Marc JB, et al. J Int AIDS Soc. 2025 Feb;28(2):e26419. doi: 10.1002/jia2.26419. J Int AIDS Soc. 2025. PMID: 39924611 Free PMC article. Clinical Trial.
Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kg.
Natukunda E, Gaur AH, Kosalaraksa P, Hellström E, Strehlau R, Liberty A, Cox S, Leisegang R, Palaparthy R, Crowe S, Vieira V, Kersey K, Rakhmanina N. Natukunda E, et al. J Int AIDS Soc. 2025 Feb;28(2):e26414. doi: 10.1002/jia2.26414. J Int AIDS Soc. 2025. PMID: 39888251 Free PMC article. Clinical Trial.
Benefits of HIV-1 transmission cluster surveillance: a French retrospective observational study of the molecular and epidemiological co-evolution of recent circulating recombinant forms 94 and 132.
Wirden M, Tombette F, Lambert-Niclot S, Chaix ML, Marque-Juillet S, Bouvier-Alias M, Roquebert B, Machado M, Avettand-Fenoel V, Gantner P, Alidjinou EK, Stefic K, Plantier JC, Calvez V, Descamps D, Marcelin AG, Visseaux B; ANRS‐MIE resistance study group. Wirden M, et al. J Int AIDS Soc. 2025 Feb;28(2):e26416. doi: 10.1002/jia2.26416. J Int AIDS Soc. 2025. PMID: 39875664 Free PMC article.
Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084.
Delany-Moretlwe S, Hanscom B, Guo X, Nkabiito C, Mandima P, Nahirya PN, Mpendo J, Bhondai-Mhuri M, Mgodi N, Berhanu R, Farrior J, Piwowar-Manning E, Ford SL, Hendrix CW, Rinehart AR, Rooney JF, Adeyeye A, Landovitz RJ, Cohen MS, Hosseinipour MC, Marzinke MA; HPTN 084 Study Team. Delany-Moretlwe S, et al. J Int AIDS Soc. 2025 Jan;28(1):e26401. doi: 10.1002/jia2.26401. J Int AIDS Soc. 2025. PMID: 39748218 Free PMC article. Clinical Trial.
High recent PrEP adherence with point-of-care urine tenofovir testing and adherence counselling among young African women: results from the INSIGHT cohort.
Gati Mirembe B, Donnell D, Krows M, Zwane Z, Bukusi E, Panchia R, Louw C, Mwelase N, Selepe P, Senne M, Naidoo L, Chihana R, Kasaro M, Nuwagaba-Biribonwoha H, Kotze P, Gill K, MacDonald P, vanHeerden A, Bosman S, Jaggernath M, du Preez P, Ward A, Peters RPH, Delany-Moretlwe S, Peacock S, Johnson R, Caucutt J, Morrison S, Wang G, Gandhi M, Velloza J, Heffron R, Celum C; INSIGHT Study Team. Gati Mirembe B, et al. J Int AIDS Soc. 2024 Dec;27(12):e26389. doi: 10.1002/jia2.26389. J Int AIDS Soc. 2024. PMID: 39653676 Free PMC article.
Retention on antiretroviral therapy and drivers of lost-to-follow up in the Central African Republic: a longitudinal analysis.
Tekpa G, Inikoutiyo J, Yonli C, Noguera C, Lujwiro PP, Gigout L, Hachimou A, Romaric S, Mabaïlao R, Banthas MC, Mbia LB, Mbay PR, Romuald K, Sana A, Roberte F, Moretó-Planas L, Goemaere E, Mekiedje C, Ouanekpone S, Núñez-Andrés MA, Hoibak S, Vallès X. Tekpa G, et al. J Int AIDS Soc. 2024 Dec;27(12):e26387. doi: 10.1002/jia2.26387. J Int AIDS Soc. 2024. PMID: 39639546 Free PMC article.
Recent infection testing to inform HIV prevention responses and surveillance in a programme context: lessons from implementation within a nationally scaled female sex worker programme in Zimbabwe.
Jones HS, Machingura F, Gaihai L, Makamba M, Chanyowedza T, Masvikeni P, Matsikire E, Matambanadzo P, Musemburi S, Chida PN, Dirawo J, Mugurungi O, Bourdin S, Hensen B, Platt L, Murphy G, Hargreaves JR, Cowan FM, Rice B. Jones HS, et al. J Int AIDS Soc. 2024 Dec;27(12):e26391. doi: 10.1002/jia2.26391. J Int AIDS Soc. 2024. PMID: 39587889 Free PMC article.
Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long-acting cabotegravir/rilpivirine among early adopters in three U.S. clinics.
Christopoulos KA, Smith MB, Pareek P, Dawdani A, Erguera XA, Dance KV, Walker RS, Grochowski J, Mayorga-Munoz F, Hickey MD, Johnson MO, Sauceda J, Gutierrez JI Jr, Montgomery ET, Colasanti JA, Collins LF, McNulty MC, Koester KA. Christopoulos KA, et al. J Int AIDS Soc. 2024 Nov;27(11):e26394. doi: 10.1002/jia2.26394. J Int AIDS Soc. 2024. PMID: 39568168 Free PMC article.
Pre-exposure prophylaxis implementation gaps among people vulnerable to HIV acquisition: a cross-sectional analysis in two communities in western Kenya, 2021-2023.
Romo ML, Schluck G, Kosgei J, Akoth C, Bor R, Langat D, Charles C, Adjei P, Gayle B, LeeVan E, Chang D, Yates A, Yacovone M, Ake JA, Sawe F, Crowell TA; Multinational Observational Cohort of HIV and other Infections (MOCHI) Study Group. Romo ML, et al. J Int AIDS Soc. 2024 Nov;27(11):e26372. doi: 10.1002/jia2.26372. J Int AIDS Soc. 2024. PMID: 39496511 Free PMC article.
Power, data and social accountability: defining a community-led monitoring model for strengthened health service delivery.
Rambau N, Policar S, Sharp AR, Lankiewicz E, Nsubuga A, Chimhanda L, Yawa A, Mwehonge K, Tobaiwa DD, Alfred GM, Kavanagh MM, Russell A, Baptiste S, Kalama OM, Marte RM, Ledan N, Honermann B, Lauer K, Rafif N, Perez S, Sun G, Grimsrud A, Sprague L, Mienies K. Rambau N, et al. J Int AIDS Soc. 2024 Nov;27(11):e26374. doi: 10.1002/jia2.26374. J Int AIDS Soc. 2024. PMID: 39448552 Free PMC article.
Very high HIV prevalence and incidence among men who have sex with men and transgender women in Indonesia: a retrospective observational cohort study in Bali and Jakarta, 2017-2020.
Wardhani BDK, Grulich AE, Kawi NH, Prasetia Y, Luis H, Wirawan GBS, Pradnyani PE, Kaldor J, Law M, Ronoatmodjo S, Sihotang EP, Januraga PP, Bavinton BR. Wardhani BDK, et al. J Int AIDS Soc. 2024 Nov;27(11):e26386. doi: 10.1002/jia2.26386. J Int AIDS Soc. 2024. PMID: 39448551 Free PMC article.
Prevalence and co-occurrence of symptoms of mental and substance use disorders among people with HIV age 40 and older in low- and middle-income countries: a cross-sectional study.
Parcesepe AM, Stockton M, Bernard C, Kanguya T, Kwobah EK, Lopez A, Murenzi G, Ross J, Minga A, Maruri F, Tlali M, Goodrich S, Perazzo H, Musabyimana F, Nimkar S, Lancaster K, Consortium I. Parcesepe AM, et al. J Int AIDS Soc. 2024 Oct;27(10):e26359. doi: 10.1002/jia2.26359. J Int AIDS Soc. 2024. PMID: 39375051 Free PMC article.
The impact of analytical treatment interruptions and trial interventions on time to viral re-suppression in people living with HIV restarting ART in cure-related clinical studies: a systematic review and meta-analysis.
Lee MJ, Eason M, Castagna A, Laura G, De Scheerder MA, Riley J, Tebas P, Gunst J, Søgaard O, Florence E, Kroon E, De Souza M, Mothe B, Caskey M, Fidler S. Lee MJ, et al. J Int AIDS Soc. 2024 Aug;27(8):e26349. doi: 10.1002/jia2.26349. J Int AIDS Soc. 2024. PMID: 39155436 Free PMC article.
Assessing the HIV care continuum among transgender women during 11 years of follow-up: results from the Netherlands' ATHENA observational cohort.
Jongen VW, Daans C, van Sighem A, Schim van der Loeff M, Hage K, Welling C, von Vaupel-Klein A, den Heijer M, Peters EJG, van der Valk M, Reiss P, Prins M, Hoornenborg E; ATHENA observational HIV cohort. Jongen VW, et al. J Int AIDS Soc. 2024 Aug;27(8):e26317. doi: 10.1002/jia2.26317. J Int AIDS Soc. 2024. PMID: 39118295 Free PMC article.
Acceptability, usability, and willingness to pay for HIV self-test kits distributed through community-based, PLHIV network-led and private practitioners models in India: Results from the STAR III Initiative.
Laxmeshwar C, Hegde A, Dange A, Mariyappan K, Soosai M, Mane S, Sivasubramanian M, Doddamane M, Mukherjee M, Shreenivas GS, Pardesi M, Jambhale V, Rao Pakkela V, Arumugam V, Rungta V, Bansal Y, Chaudary J, Yeldandi V, Periasamy M, Uthappa C, Chawla S, Upadhyaya S, Nyendak M, Chakrapani V, Godbole S, Verma V, Singh Kushwaha B, Das C, Rajan S, Kumar Puri A, Prasada Rao JVR, Bhatnagar T, Reddy DCS, Green K. Laxmeshwar C, et al. J Int AIDS Soc. 2024 Aug;27(8):e26348. doi: 10.1002/jia2.26348. J Int AIDS Soc. 2024. PMID: 39118294 Free PMC article.
"…because the social work never ends": a qualitative study exploring how NGOs responded to emerging needs while upholding responsibility to HIV prevention and treatment during the war in Ukraine.
Lazarus L, McClarty LM, Herpai N, Pavlova D, Tarasova T, Gnatenko A, Bondar T, Lorway R, Becker ML; Dynamics Study Team. Lazarus L, et al. J Int AIDS Soc. 2024 Jul;27 Suppl 3(Suppl 3):e26309. doi: 10.1002/jia2.26309. J Int AIDS Soc. 2024. PMID: 39030857 Free PMC article.
A citizen science approach to develop a digital intervention to reduce HIV stigma and promote HIV self-testing among adolescents and young adults: a mixed methods analysis from Kazakhstan.
Davis A, Rosenthal SL, Tucker JD, Balabekova O, Nyblade L, Sun Y, Gryazev D, Lunze K, Landers SE, Tang W, Kuskulov A, Gulyayev V, Terlikbayeva A, Primbetova S, Mergenova G; JasSpark Study Team. Davis A, et al. J Int AIDS Soc. 2024 Jul;27 Suppl 3(Suppl 3):e26314. doi: 10.1002/jia2.26314. J Int AIDS Soc. 2024. PMID: 39030847 Free PMC article.
The effects of regular home delivery of HIV self-testing and follow-up counselling on HIV testing and prevention outcomes in men who have sex with men who test infrequently in the United States: a pragmatic, virtual randomized controlled trial.
Wray TB, Chan PA, Klausner JD, Ward LM, Ocean EMS, Carr DJ, Guigayoma JP, Nadkarni S. Wray TB, et al. J Int AIDS Soc. 2024 Jul;27(7):e26318. doi: 10.1002/jia2.26318. J Int AIDS Soc. 2024. PMID: 39020453 Free PMC article. Clinical Trial.
Advancing Programme Science approaches to understand gaps in HIV prevention programme coverage for key populations in 12 Nigerian states: findings from the 2020 Integrated Biological and Behavioural Surveillance Survey.
McClarty LM, Green K, Leung S, Ejeckam C, Adesina A, Shaw SY, Neufeld B, Isac S, Emmanuel F, Blanchard JF, Aliyu G. McClarty LM, et al. J Int AIDS Soc. 2024 Jul;27 Suppl 2(Suppl 2):e26269. doi: 10.1002/jia2.26269. J Int AIDS Soc. 2024. PMID: 38988042 Free PMC article.
Using a Programme Science approach to substantially reduce the risk of HIV transmission and acquisition in sex transactions among female sex workers in Zimbabwe.
Cowan FM, Musemburi S, Matambanadzo P, Chida P, Steen R, Makandwa R, Chabata ST, Takura A, Sheets A, Yekeye R, Mugurungi O, Hensen B, Busza J, Hargreaves JR. Cowan FM, et al. J Int AIDS Soc. 2024 Jul;27 Suppl 2(Suppl 2):e26262. doi: 10.1002/jia2.26262. J Int AIDS Soc. 2024. PMID: 38988032 Free PMC article.
A sub-national HIV epidemic appraisal in Kenya: a new approach for identifying priority geographies, populations and programmes for optimizing coverage for HIV prevention.
Banadakoppa Manjappa R, Bhattacharjee P, Shaw SY, Gitonga J, Kioko J, Songok F, Emmanuel F, Arimi P, Musyoki H, Masha RL, Blanchard J. Banadakoppa Manjappa R, et al. J Int AIDS Soc. 2024 Jul;27 Suppl 2(Suppl 2):e26245. doi: 10.1002/jia2.26245. J Int AIDS Soc. 2024. PMID: 38982894 Free PMC article.
2,748 results